Home-made matrix

Scanning electron micrograph of human fibroblast (gray) intercalating within three-dimensional in vivo-like cell-derived matrix (cyan). Credit: Courtesy of Michal Jarnik and Edna Cukierman / Fox Chase Cancer Center" />Scanning electron micrograph of human fibroblast (gray) intercalating within three-dimensional in vivo-like cell-derived matrix (cyan). Credit: Courtesy of Michal Jarnik and Edn

Written byJosh P. Roberts
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

User:
Edna Cukierman, Fox Chase Cancer Center, Philadelphia

Project:
Discerning the interplay between tumors and their microenvironment in the pathology of cancer

Problem:
Not enough is known about the differences among extracellular matrices (ECMs) of different tissues, and in different pathologic states, to recapitulate them in vitro from commercial sources.

Solution:
Cukierman induces fibroblasts (from diseased or normal tissue) to lay down a stromal matrix. She treats the confluent fibroblast cultures with an alkaline detergent solution to remove the cells, which leaves behind complex substrates of fibronectin, collagen, and other proteins. This, in turn, lets her interrogate how the differences among these 3-D scaffolds affect the behavior of tumors cultured on them.

Microenvironments change as the cancer progresses, Cukierman explains, and they're also active participants in cancer. Much of her research involves comparing the molecular characteristics and signaling capabilities of fibroblastic extracellular matrices - both how these change during tumor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies